Market Place
Market Place
Post Enquiry
2017 – Recap of Warning Letters, Import Alerts and Non-Compliances
Data
integrity continued to be a hot topic in the pharmaceutical industry through
2017. According to
Mid-2017 Recap of FDA Warning Letters, Import Alerts & EU Non-Compliances
Last year, data
integrity was a hot topic of discussion in the pharmaceutical industry.
According t
FDA problems at Pfizer’s US facility continue; China FDA joins ICH
This week in our compliance round up, we look at the continuing problems at Pfizer’s McPherson
